Vicky Hahne Form 4 Celcuity / Vicky Hahne ownership change

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

1. Name and Address of Reporting Person^*

Hahne Vicky

(Last)

(First)

(Middle)

16305 36TH AVENUE N.

SUITE 100

(Street)

MINNEAPOLIS

55446

(City)

(State)

(Zip)

2. Issuer Name and Ticker or Trading Symbol
Celcuity Inc. [ CELC ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director	10% Owner
X	Officer (give title below)	Other (specify below)
Chief Financial Officer

3. Date of Earliest Transaction (Month/Day/Year)
05/17/2022

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	Amount	(A) or (D)	Price		6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
Common Stock								12,903⁽¹⁾	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares	8. Price of Derivative Security (Instr. 5)		10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
Stock Option (right to buy)	$8.4							⁽²⁾	05/17/2027	Common Stock	37,500		37,500	D
Stock Option (right to buy)	$23.48	05/17/2022		D			3,000	⁽³⁾	07/05/2028	Common Stock	3,000	⁽¹⁴⁾	0	D
Stock Option (right to buy)	$5.5	05/17/2022		A		3,000		⁽³⁾	07/05/2028	Common Stock	3,000	⁽¹⁴⁾	3,000	D
Stock Option (right to buy)	$25.77	05/17/2022		D			932	⁽⁴⁾	10/17/2028	Common Stock	932	⁽¹⁴⁾	0	D
Stock Option (right to buy)	$5.5	05/17/2022		A		932		⁽⁴⁾	10/17/2028	Common Stock	932	⁽¹⁴⁾	932	D
Stock Option (right to buy)	$19.72	05/17/2022		D			3,000	⁽⁵⁾	08/12/2029	Common Stock	3,000	⁽¹⁴⁾	0	D
Stock Option (right to buy)	$5.5	05/17/2022		A		3,000		⁽⁵⁾	08/12/2029	Common Stock	3,000	⁽¹⁴⁾	3,000	D
Stock Option (right to buy)	$5.9							⁽⁶⁾	08/12/2030	Common Stock	10,000		10,000	D
Stock Option (right to buy)	$10.35	05/17/2022		D			1,122	⁽⁷⁾	12/28/2030	Common Stock	1,122	⁽¹⁴⁾	0	D
Stock Option (right to buy)	$5.5	05/17/2022		A		1,122		⁽⁷⁾	12/28/2030	Common Stock	1,122	⁽¹⁴⁾	1,122	D
Stock Option (right to buy)	$14.84	05/17/2022		D			1,301	⁽⁸⁾	02/02/2031	Common Stock	1,301	⁽¹⁴⁾	0	D
Stock Option (right to buy)	$5.5	05/17/2022		A		1,301		⁽⁸⁾	02/02/2031	Common Stock	1,301	⁽¹⁴⁾	1,301	D
Stock Option (right to buy)	$15.92	05/17/2022		D			1,204	⁽⁹⁾	03/18/2031	Common Stock	1,204	⁽¹⁴⁾	0	D
Stock Option (right to buy)	$5.5	05/17/2022		A		1,204		⁽⁹⁾	03/18/2031	Common Stock	1,204	⁽¹⁴⁾	1,204	D
Stock Option (right to buy)	$27.94	05/17/2022		D			3,806	⁽¹⁰⁾	04/12/2031	Common Stock	3,806	⁽¹⁴⁾	0	D
Stock Option (right to buy)	$5.5	05/17/2022		A		3,806		⁽¹⁰⁾	04/12/2031	Common Stock	3,806	⁽¹⁴⁾	3,806	D
Stock Option (right to buy)	$20.04	05/17/2022		D			15,000	⁽¹¹⁾	08/11/2031	Common Stock	15,000	⁽¹⁴⁾	0	D
Stock Option (right to buy)	$5.5	05/17/2022		A		15,000		⁽¹¹⁾	08/11/2031	Common Stock	15,000	⁽¹⁴⁾	15,000	D
Stock Option (right to buy)	$17.19	05/17/2022		D			821	⁽¹²⁾	10/27/2031	Common Stock	821	⁽¹⁴⁾	0	D
Stock Option (right to buy)	$5.5	05/17/2022		A		821		⁽¹²⁾	10/27/2031	Common Stock	821	⁽¹⁴⁾	821	D
Stock Option (Right to Buy)	$5.5	05/17/2022		A		31,930		⁽¹³⁾	05/17/2032	Common Stock	31,930	$0	31,930	D

Explanation of Responses:

1. Includes 1,972 shares acquired on October 29, 2021 and 2,000 shares acquired on April 30, 2022 pursuant to the Issuer's Employee Stock Purchase Plan.

2. Fully vested.

3. 750 shares vest on 7/5/19; the remaining 2,250 shares vest 1/36th per month thereafter.

4. 233 shares vest on 10/17/19; the remaining 699 shares vest 1/36th per month thereafter.

5. 750 shares vest on 8/12/20; the remaining 2,250 shares vest 1/36th per month thereafter.

6. 2,500 shares vest on 8/12/21; the remaining 7,500 shares vest 1/36th per month thereafter.

7. 280 shares vest on 12/29/21; the remaining 842 shares vest 1/36th per month thereafter.

8. 325 shares vest on 2/2/22; the remaining 976 shares vest 1/36th per month thereafter.

9. 301 shares vest on 3/18/22; the remaining 903 shares vest 1/36th per month thereafter.

10. 952 shares vest on 4/12/22; the remaining 2,854 shares vest 1/36th per month thereafter.

11. 3,750 shares vest on 8/11/22; the remaining 11,250 shares vest 1/36th per month thereafter.

12. 205 shares vest on 10/27/22; the remaining 616 shares vest 1/36th per month thereafter.

13. These shares vest in equal amounts over fourteen (14) months, beginning June 1, 2022.

14. The transactions reported herein reflect a one-time stock option repricing (the "Option Repricing") effective on May 17, 2022 and are being reported in this manner solely to comply with the technical reporting requirements under Section 16(a) of the Securities Exchange Act of 1934. Pursuant to the Option Repricing, the exercise price of the Stock Option has been amended to reduce such exercise price to $5.50 per share, the closing price of the issuer's common stock on The Nasdaq Capital Market as of the date of such repricing. There have been no other changes to the terms of the Stock Option.

	/s/ Eric O. Madson as Attorney-in-Fact for Vicky Hahne pursuant to Power of Attorney previously filed.	05/19/2022
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

Vicky Hahne Form 4Celcuity / Vicky Hahne ownership change